| Individual Articles - Jul/Aug 2004 - Wound Care |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
PreScription - Categories of Pharmaceutial Compounding
Allen Loyd V Jr
|
Jul/Aug 2004
Pg. 242
|
Book and Literature Reviews
Reed-Kane Dana, Foy Elizabeth, MacCara Mary E
|
Jul/Aug 2004
Pg. 244-249
|
A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards
Newton David W, Trissel Lawrence A
|
Jul/Aug 2004
Pg. 251-263
|
Case Report: Wound Care of a Diabetic Foot Ulcer
Wynn Tom
|
Jul/Aug 2004
Pg. 265-267
|
Case Reports: Their Impact
Wynn Tom, Thompson Chad
|
Jul/Aug 2004
Pg. 266
|
Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
|
Jul/Aug 2004
Pg. 269-274
|
Warts: Facts and Therapy (Patient Handout)
Kuntz Rachael
|
Jul/Aug 2004
Pg. 275
|
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 2
Davidson Gigi S
|
Jul/Aug 2004
Pg. 277-283
|
Rationale for a Pharmacists' Pharmacopeia
Allen Loyd V Jr
|
Jul/Aug 2004
Pg. 285-287
|
Basics of Compounding for Fungal Sinusitis
Allen Loyd V Jr
|
Jul/Aug 2004
Pg. 289-291
|
Amphotericin 100-mcg/mL Nasal Irrigation/Spray
Allen Loyd V Jr
|
Jul/Aug 2004
Pg. 290
|
Ketoconazole 1% Nasal Irrigation/Spray
Allen Loyd V Jr
|
Jul/Aug 2004
Pg. 290
|
Miconazole 1% Nasal Irrigation/Spray
Allen Loyd V Jr
|
Jul/Aug 2004
Pg. 290
|
Nystatin 50,000-Units/mL Nasal Irrigation
Allen Loyd V Jr
|
Jul/Aug 2004
Pg. 290
|
Standard Operating Procedure: Determining and Documenting the Commercial Unavailability of a Manufactured Drug Product
Allen Loyd V Jr
|
Jul/Aug 2004
Pg. 292-293
|
Calculations
Prince Shelly J
|
Jul/Aug 2004
Pg. 294
|
Diltiazem 2% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Jul/Aug 2004
Pg. 295
|
Diphenhydramine HCl 0.1%, Lidocaine HCl 1%, Misoprostol 0.0024% and Triamcinolone Acetonide 0.12% Oral Rinse
Allen Loyd V Jr
|
Jul/Aug 2004
Pg. 296
|
Estradiol 0.01% Wound Gel
Allen Loyd V Jr
|
Jul/Aug 2004
Pg. 297
|
Lidocaine HCl 2%, Misoprostol 0.0024% and Phenytoin 2% Topical Wound Powder
Allen Loyd V Jr
|
Jul/Aug 2004
Pg. 298
|
Metronidazole 2%, Misoprostol 0.0024% and Phenytoin 5% Topical Gel
Allen Loyd V Jr
|
Jul/Aug 2004
Pg. 299
|
Metronidazole 2% Topical Gel
Allen Loyd V Jr
|
Jul/Aug 2004
Pg. 300
|
Pentoxifylline 5% Topical Cream
Allen Loyd V Jr
|
Jul/Aug 2004
Pg. 301
|
Tretinoin 0.1% and Lidocaine HCl 0.5% Topical Gel
Allen Loyd V Jr
|
Jul/Aug 2004
Pg. 302
|
Veterinary Wound Dressing
Allen Loyd V Jr
|
Jul/Aug 2004
Pg. 303
|
Wound Cleansing Spray
Allen Loyd V Jr
|
Jul/Aug 2004
Pg. 304
|
Quality-Control Analytical Methods: Gas Chromatography
Kupiec Thomas C
|
Jul/Aug 2004
Pg. 305-309
|
Enhanced Release of Diazepam from Hollow-Type Suppositories
Kaewnopparat N, Kaewnopparat S, Rojanarat W, Ingkatawornwong S
|
Jul/Aug 2004
Pg. 310-312
|
Efficacy and Tolerability of Compounded Bioidentical Hormone Replacement Therapy
Vigesaa Kristy A, Downhour Nathan P, Chui Michelle A, Cappellini Linda, Musil John D, McCallian Dennis J
|
Jul/Aug 2004
Pg. 313-319
|
PostScription: What is Evidence-Based Medicine?
Ashworth Lisa D
|
Jul/Aug 2004
Pg. 320
|
| Return to Top |
